131 related articles for article (PubMed ID: 22307036)
1. An AAV2/5 vector enhances safety of gene transfer to the mouse salivary gland.
Geguchadze RN; Machen L; Zourelias L; Gallo PH; Passineau MJ
J Dent Res; 2012 Apr; 91(4):382-6. PubMed ID: 22307036
[TBL] [Abstract][Full Text] [Related]
2. Pseudotyped adeno-associated viral vectors for gene transfer in dermal fibroblasts: implications for wound-healing applications.
Balaji S; King A; Dhamija Y; Le LD; Shaaban AF; Crombleholme TM; Keswani SG
J Surg Res; 2013 Sep; 184(1):691-8. PubMed ID: 23590866
[TBL] [Abstract][Full Text] [Related]
3. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes.
Halbert CL; Rutledge EA; Allen JM; Russell DW; Miller AD
J Virol; 2000 Feb; 74(3):1524-32. PubMed ID: 10627564
[TBL] [Abstract][Full Text] [Related]
4. Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors.
Kay CN; Ryals RC; Aslanidi GV; Min SH; Ruan Q; Sun J; Dyka FM; Kasuga D; Ayala AE; Van Vliet K; Agbandje-McKenna M; Hauswirth WW; Boye SL; Boye SE
PLoS One; 2013; 8(4):e62097. PubMed ID: 23637972
[TBL] [Abstract][Full Text] [Related]
5. Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors.
Chai Z; Zhang X; Dobbins AL; Frost EA; Samulski RJ; Li C
Viruses; 2019 Dec; 11(12):. PubMed ID: 31835440
[TBL] [Abstract][Full Text] [Related]
6. Comparison of gene transfer to the murine liver following intraperitoneal and intraportal delivery of hepatotropic AAV pseudo-serotypes.
Dane AP; Wowro SJ; Cunningham SC; Alexander IE
Gene Ther; 2013 Apr; 20(4):460-4. PubMed ID: 22895507
[TBL] [Abstract][Full Text] [Related]
7. Enhanced transduction of mouse salivary glands with AAV5-based vectors.
Katano H; Kok MR; Cotrim AP; Yamano S; Schmidt M; Afione S; Baum BJ; Chiorini JA
Gene Ther; 2006 Apr; 13(7):594-601. PubMed ID: 16341060
[TBL] [Abstract][Full Text] [Related]
8. Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.
Jayandharan GR; Zhong L; Sack BK; Rivers AE; Li M; Li B; Herzog RW; Srivastava A
Hum Gene Ther; 2010 Mar; 21(3):271-83. PubMed ID: 19788390
[TBL] [Abstract][Full Text] [Related]
9. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
[TBL] [Abstract][Full Text] [Related]
10. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
11. AAV5-mediated gene transfer to the parotid glands of non-human primates.
Voutetakis A; Zheng C; Cotrim AP; Mineshiba F; Afione S; Roescher N; Swaim WD; Metzger M; Eckhaus MA; Donahue RE; Dunbar CE; Chiorini JA; Baum BJ
Gene Ther; 2010 Jan; 17(1):50-60. PubMed ID: 19759566
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models.
Markusic DM; Nichols TC; Merricks EP; Palaschak B; Zolotukhin I; Marsic D; Zolotukhin S; Srivastava A; Herzog RW
J Transl Med; 2017 May; 15(1):94. PubMed ID: 28460646
[TBL] [Abstract][Full Text] [Related]
14. Bioengineering of AAV2 capsid at specific serine, threonine, or lysine residues improves its transduction efficiency in vitro and in vivo.
Gabriel N; Hareendran S; Sen D; Gadkari RA; Sudha G; Selot R; Hussain M; Dhaksnamoorthy R; Samuel R; Srinivasan N; Srivastava A; Jayandharan GR
Hum Gene Ther Methods; 2013 Apr; 24(2):80-93. PubMed ID: 23379478
[TBL] [Abstract][Full Text] [Related]
15. Pseudotyped adeno-associated viral vector tropism and transduction efficiencies in murine wound healing.
Keswani SG; Balaji S; Le L; Leung A; Lim FY; Habli M; Jones HN; Wilson JM; Crombleholme TM
Wound Repair Regen; 2012; 20(4):592-600. PubMed ID: 22713157
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy of five adeno-associated virus vectors for transducing dorsal raphé nucleus cells in the mouse.
Vincent M; Gao G; Jacobson L
J Neurosci Methods; 2014 Sep; 235():189-92. PubMed ID: 25046366
[TBL] [Abstract][Full Text] [Related]
17. AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.
Su H; Huang Y; Takagawa J; Barcena A; Arakawa-Hoyt J; Ye J; Grossman W; Kan YW
Gene Ther; 2006 Nov; 13(21):1495-502. PubMed ID: 16775632
[TBL] [Abstract][Full Text] [Related]
18. Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors.
Halbert CL; Allen JM; Miller AD
J Virol; 2001 Jul; 75(14):6615-24. PubMed ID: 11413329
[TBL] [Abstract][Full Text] [Related]
19. Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors.
Thomas CE; Storm TA; Huang Z; Kay MA
J Virol; 2004 Mar; 78(6):3110-22. PubMed ID: 14990730
[TBL] [Abstract][Full Text] [Related]
20. AAV-mediated liver-directed gene therapy.
Sands MS
Methods Mol Biol; 2011; 807():141-57. PubMed ID: 22034029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
